2026-01-28 - Analysis Report
**Company Overview:** Philip Morris International is a multinational tobacco conglomerate that produces a range of tobacco products.

**Return Rate Comparison:**

* Cumulative return of review stock: 142.78%
* Cumulative return of comparison stock (S&P 500, VOO): 128.51%
* Divergence (max: 51.00, min: -64.60, current: 11.00, relative divergence: 65.40%)

The review stock has a higher cumulative return compared to the S&P 500, with a divergence of 11.00 and a relative divergence of 65.40%. This indicates that the review stock has performed better than the S&P 500 over the specified period.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -26.0% | 22.9% | -35.0% | 0.5 | 103.9B |
| 2017-2019  | -1.0% | 22.9% | -27.0% | 0.5 | 132.4B |
| 2018-2020  | -3.0% | 31.0% | -27.0% | 0.8 | 128.9B |
| 2019-2021  | 40.0% | 31.0% | -24.0% | 0.8 | 147.9B |
| 2020-2022  | 36.0% | 31.0% | 32.0% | 0.7 | 157.6B |
| 2021-2023  | 26.0% | 19.7% | 8.0% | 0.5 | 146.4B |
| 2022-2024  | 32.0% | 19.7% | 3.0% | 0.4 | 187.3B |
| 2023-2025  | 79.0% | 19.8% | 4.0% | 0.2 | 249.7B |

**Recent Stock Price Fluctuations:**

* Close: $178.88
* Last-market: {'price': 178.88, 'previousClose': 175.76, 'change': 1.78}
* 5-day SMA: $173.30
* 20-day SMA: $165.91
* 60-day SMA: $157.90

The review stock has experienced a sharp rebound of 1.78% in the last market fluctuation. The 5-day, 20-day, and 60-day moving averages indicate a trend of increasing prices.

**RSI, PPO Index Indicators:**

* Market Risk Indicator (MRI): 0.70
* RSI: 82.39
* PPO: 0.60
* Hybrid Signal: Buy
* Risk Level: Medium (MRI 0.70)
* Recent (20 days) relative divergence change: 2.20 (+): improving
* 7-day Rank change: -4 (-): rank down
* 7-day Dynamic Expected Return change: -7.40 (-): worsening
* Expected Return (%): -14.90%

The RSI and PPO indicators indicate a moderate risk profile, with the RSI close to the overbought threshold. The market risk indicator is 0.70, indicating a medium-risk profile. The hybrid signal is buy, and the risk level is medium.

**Recent News & Significant Events:**

* [2026-01-12] Earnings Preview: What to Expect From Philip Morrisâ€™ Report - Yahoo Finance
* [2026-01-27] Philip Morris International Stock Shares $75 Bil Success With Investors - Trefis
* [2026-01-24] Philip Morris International: A Stock Analysis You Can't Miss - The Motley Fool
* [2026-01-24] Is Philip Morris International (PM) Still Attractive After Recent Share Price Surge? - simplywall.st
* [2026-01-24] Philip Morris International: A Stock Analysis You Can't Miss - Nasdaq
* [2026-01-26] Savoir Faire Capital Management L.P. Grows Stock Position in Philip Morris International Inc. $PM - MarketBeat

These recent news articles indicate positive sentiment towards Philip Morris International, with analysts praising its success and attractiveness.

**Analyst Opinions:**

* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 1.83 (~Buy)
	+ Opinions: 16
	+ Target Price (avg/high/low): 180.38 / 200.00 / 158.00

Analysts have a positive consensus, with 16 opinions indicating a buy recommendation. The mean opinion is 1.83, indicating a strong buy recommendation. The target price is between 158.00 and 200.00.

**Recent Earnings Analysis:**

| Date | EPS | Revenue |
|-----|----|---------|
| 2025-10-24 | 2.23 | 10.85 B$ |
| 2025-07-25 | 1.95 | 10.14 B$ |
| 2025-04-24 | 1.72 | 9.30 B$ |
| 2024-10-24 | 1.98 | 9.91 B$ |
| 2025-10-24 | 1.98 | 9.91 B$ |

The company has reported increasing earnings per share (EPS) and revenue over the past year, with a significant increase in revenue in the most recent quarter.

**Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.85B | 67.85% |
| 2025-06-30 | $10.14B | 67.66% |
| 2025-03-31 | $9.30B | 67.32% |
| 2024-12-31 | $9.71B | 64.73% |
| 2024-09-30 | $9.91B | 66.04% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $-10.91B | -31.87% |
| 2025-06-30 | $-11.97B | -25.40% |
| 2025-03-31 | $-10.90B | -24.68% |
| 2024-12-31 | $-11.75B | 4.93% |
| 2024-09-30 | $-9.69B | -31.79% |

The company has experienced increasing revenue and profit margins over the past year, with a significant increase in revenue in the most recent quarter. However, the company has also experienced a significant decline in equity and return on equity (ROE) over the past year.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.